erlotinib hydrochloride has been researched along with morusin in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (morusin) | Trials (morusin) | Recent Studies (post-2010) (morusin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 76 | 1 | 60 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | morusin (IC50) |
|---|---|---|---|
| Phosphotyrosine protein phosphatase | Mycobacterium tuberculosis | 5.254 | |
| Low molecular weight protein-tyrosine phosphatase A | Mycobacterium tuberculosis H37Rv | 4.65 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, GY; Choi, YH; Min, TR; Park, HJ; Park, SH | 1 |
1 other study(ies) available for erlotinib hydrochloride and morusin
| Article | Year |
|---|---|
Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Flavonoids; Humans; Lung Neoplasms; Molecular Docking Simulation; Mutation; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; STAT3 Transcription Factor | 2018 |